'You're Fine.' Why Delays in MS Diagnosis Matter. - The Good Men Project
A leading cause of neurologic disability in young adults, it affects nearly 1 million people in the United States.
Source: goodmenproject.com
Daniel Ontaneda News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Daniel Ontaneda. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Daniel Ontaneda Today - Breaking & Trending Today
Conference Chair Dr Daniel Ontaneda Previews ACTRIMS Forum 2024
Daniel Ontaneda, MD, PhD, Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2024 chair, discussed what attendees can expect at this year's meeting, as well as how the theme of "Breaking Barriers in MS" will be implemented.
Source: ajmc.com
ACTRIMS 2023: Learning, lectures and leaving with hope | Multiple Sclerosis News Today
Jenn Powell, who lives with secondary progressive MS, sums up the ACTRIMS Forum 2023 from a patient's perspective.
Source: multiplesclerosisnewstoday.com
'Tantalizing' New Data for Ibudilast in Multiple Sclerosis
New data from SPRINT-MS show that the drug has beneficial effects on slowly evolving lesions in people with multiple sclerosis, perhaps by abrogating chronic active lesions.
Source: medscape.com
MRI a Viable Alternative to Lumbar Puncture for MS Diagnosis?
The central vein sign is an emerging neuroimaging biomarker for multiple sclerosis that may reduce the need for lumbar puncture to detect oligoclonal bands in CSF, a pilot study shows.
Source: medscape.com